BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Purssell H, Whorwell PJ, Athwal VS, Vasant DH. Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence? World J Hepatol 2021; 13(12): 1816-1827 [PMID: 35069992 DOI: 10.4254/wjh.v13.i12.1816]
URL: https://www.wjgnet.com/1007-9327/full/v13/i12/1816.htm
Number Citing Articles
1
Shanshan Wu, Changzheng Yuan, Zhirong Yang, Si Liu, Qian Zhang, Shutian Zhang, Shengtao Zhu. Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort studyBMC Medicine 2022; 20(1) doi: 10.1186/s12916-022-02460-8
2
Huw Purssell, Lucy Bennett, Oliver Street, Karen Piper Hanley, Neil Hanley, Dipesh H. Vasant, Varinder S. Athwal. The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional studyScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35774-5
3
Francisco Idalsoaga, Gustavo Ayares, Hanna Blaney, Daniel Cabrera, Javier Chahuan, Hugo Monrroy, Ayah Matar, Houssam Halawi, Marco Arrese, Juan Pablo Arab, Luis Antonio Díaz. Neurogastroenterology and motility disorders in patients with cirrhosisHepatology Communications 2025; 9(1) doi: 10.1097/HC9.0000000000000622
4
Guangqin Xu, Shaoze Ma, Liyan Dong, Nahum Mendez-Sanchez, Hongyu Li, Xingshun Qi, Alessandro Granito. Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-AnalysisCanadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/5521239
5
Wayne Eskridge, Donna R. Cryer, Jörn M. Schattenberg, Amalia Gastaldelli, Harmeet Malhi, Alina M. Allen, Mazen Noureddin, Arun J. Sanyal. Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician PerspectiveJournal of Clinical Medicine 2023; 12(19): 6216 doi: 10.3390/jcm12196216
6
Xiaowen Yu, Xuan Chen, Jun Ouyang, Biao Xi, Defeng Wu, Ling Wei, Dongyu Xie, Yaxiang Shi. Exploring the mechanisms of Shugan-Jieyu-Jianpi formula against irritable bowel syndrome combined with non-alcoholic fatty liver disease by network pharmacology and experimental validationGrowth Factors 2025; : 1 doi: 10.1080/08977194.2025.2467135
7
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Maria Luisa Gambardella, Luigi Boccuto, Nahum Méndez-Sánchez, Francesco Luzza. Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot StudyLife 2024; 14(10): 1226 doi: 10.3390/life14101226
8
Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic reviewWorld Journal of Hepatology 2023; 15(7): 925-938 doi: 10.4254/wjh.v15.i7.925
9
Marzieh Saei Ghare Naz, Vida Ghasemi, Shabahang Amirshekari, Fahimeh Ramezani Tehrani. Polycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?Endocrinology, Diabetes & Metabolism 2024; 7(2) doi: 10.1002/edm2.477
10
Mihaela Rotaru, Ana-Maria Singeap, Alin Ciobica, Laura Huiban, Carol Stanciu, Laura Romila, Vasile Burlui, Ioannis Mavroudis, Anca Trifan. Oral Health and “Modern” Digestive Diseases: Pathophysiologic and Etiologic FactorsBiomedicines 2024; 12(8): 1854 doi: 10.3390/biomedicines12081854